非酒精性脂肪肝儿童中需临床干预的高胆固醇和高甘油三酯血症
这项多中心纵向队列研究纳入585名平均12.8岁的非酒精性脂肪肝(NAFLD)儿童,依据美国国家心肺血液研究所指南评估血脂干预指征。基线时14%的患儿低密度脂蛋白胆固醇需干预,51%的患儿甘油三酯需干预;经过1年饮食建议后,部分患儿达标,但仍有相当比例需强化饮食或药物治疗。结论认为超过半数NAFLD儿童存在需临床干预的血脂异常,应进行血脂筛查并熟悉血脂管理。
要点
- NAFLD儿童中14%基线低密度脂蛋白胆固醇需干预,51%甘油三酯需干预。
- 1年饮食建议后,51%低密度脂蛋白胆固醇达标,25%甘油三酯达标。
- 22%低密度脂蛋白胆固醇和37%甘油三酯仍符合药物干预标准。
核心结论
- 超过半数NAFLD儿童存在需临床干预的血脂异常,应进行血脂筛查。
- 照顾NAFLD儿童的临床医生应熟悉血脂管理。
研究设计与样本
- 多中心纵向队列研究,纳入NASH临床研究网络中的NAFLD儿童。
- 共585名参与者,平均年龄12.8岁,诊断时获取空腹血脂谱。
- 提供标准化饮食建议,1年后重复血脂谱并依据NHLBI指南解读。
主要发现
- 基线时14%的儿童低密度脂蛋白胆固醇需干预,51%的儿童甘油三酯需干预。
- 1年后,51%达到低密度脂蛋白胆固醇目标,27%需强化饮食和生活方式调整,22%符合药物干预标准。
- 1年后,25%通过饮食和生活方式达到甘油三酯目标,38%需高级饮食调整,37%符合降脂药物标准。
关键数值与推荐
- 低密度脂蛋白胆固醇干预指征依据NHLBI专家指南。
- 甘油三酯干预指征依据NHLBI专家指南。
- 1年后血脂目标依据NHLBI专家指南整合指南。
临床怎么用
- 对NAFLD儿童应进行血脂筛查。
- 临床医生应熟悉NAFLD儿童的血脂管理,包括饮食和药物干预指征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the percentage of children with nonalcoholic fatty liver disease (NAFLD) in whom intervention for low-density lipoprotein cholesterol or triglycerides was indicated based on National Heart, Lung, and Blood Institute guidelines. STUDY DESIGN: This multicenter, longitudinal cohort study included children with NAFLD enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases Nonalcoholic Steatohepatitis Clinical Research Network. Fasting lipid profiles were obtained at diagnosis. Standardized dietary recommendations were provided. After 1 year, lipid profiles were repeated and interpreted according to National Heart, Lung, and Blood Institute Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction. Main outcomes were meeting criteria for clinically actionable dyslipidemia at baseline, and either achieving lipid goal at follow-up or meeting criteria for ongoing intervention. RESULTS: There were 585 participants, with a mean age of 12.8 years. The prevalence of children warranting intervention for low-density lipoprotein cholesterol at baseline was 14%. After 1 year of recommended dietary changes, 51% achieved goal low-density lipoprotein cholesterol, 27% qualified for enhanced dietary and lifestyle modifications, and 22% met criteria for pharmacologic intervention. Elevated triglycerides were more prevalent, with 51% meeting criteria for intervention. At 1 year, 25% achieved goal triglycerides with diet and lifestyle changes, 38% met criteria for advanced dietary modifications, and 37% qualified for antihyperlipidemic medications. CONCLUSIONS: More than one-half of children with NAFLD met intervention thresholds for dyslipidemia. Based on the burden of clinically relevant dyslipidemia, lipid screening in children with NAFLD is warranted. Clinicians caring for children with NAFLD should be familiar with lipid management.
引用
- Harlow KE, Africa JA, Wells A, et al. Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease. J Pediatr. 2018. PMID: 29661561. doi:10.1016/j.jpeds.2018.02.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。